Track topics on Twitter Track topics that are important to you
NovaBay Pharmaceuticals announced a $4 million net loss in the first quarter of 2017 compared with a net loss of $5.1 million in the same quarter of last year. Research and development costs declined from $0.9 million in 2016 to $0.1 million this quarter, while sales and marketing expenses increased from $3.1 million to $3.7 million, according to a press release.
Original Article: NovaBay reports $4 million quarterly lossNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...